AbbVie Inc.

NYSE: ABBV · Real-Time Price · USD
205.17
0.49 (0.24%)
At close: Aug 15, 2025, 9:57 AM

AbbVie Cash Flow Statement

Financials in USD. Fiscal year is January - December.
Fiscal Year FY 2024 FY 2023 FY 2022 FY 2021
Period Ending Dec 31, 2024 Dec 31, 2023 Dec 31, 2022 Dec 31, 2021
Net Income
4.29B 4.82B 11.85B 11.55B
Depreciation & Amortization
8.39B 8.7B 8.47B 8.52B
Stock-Based Compensation
911M 747M 671M 692M
Other Working Capital
-2.85B -676M 278M -1.49B
Other Non-Cash Items
9.45B 8.6B 6.15B 4.24B
Deferred Income Tax
-1.45B -2.89B -1.93B -898M
Change in Working Capital
-2.78B 2.81B -258M -1.32B
Operating Cash Flow
18.81B 22.84B 24.94B 22.78B
Capital Expenditures
-974M -777M -695M -787M
Cash Acquisitions
-17.49B -1.22B -794M -1.9B
Purchase of Investments
-73M -77M -1.44B -119M
Sales Maturities Of Investments
555M 55M 1.53B 98M
Other Investing Acitivies
-2.83B 13M 774M 366M
Investing Cash Flow
-20.82B -2.01B -623M -2.34B
Debt Repayment
7.35B -4.15B -12.43B -8.41B
Common Stock Repurchased
-1.71B -1.97B -1.49B -934M
Dividend Paid
-11.03B -10.54B -10.04B -9.26B
Other Financial Acitivies
172M -562M -840M -430M
Financial Cash Flow
-5.21B -17.22B -24.8B -19.04B
Net Cash Flow
-7.29B 3.61B -545M 1.3B
Free Cash Flow
17.83B 22.06B 24.25B 21.99B